390 related articles for article (PubMed ID: 17259989)
21. Major histocompatibility complex recognition by immune receptors: differences among T cell receptor versus antibody interactions with the VSV8/H-2Kb complex.
Witte T; Smolyar A; Spoerl R; Goyarts EC; Nathenson SG; Reinherz EL; Chang HC
Eur J Immunol; 1997 Jan; 27(1):227-33. PubMed ID: 9022023
[TBL] [Abstract][Full Text] [Related]
22. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
[TBL] [Abstract][Full Text] [Related]
23. Recognition of an MHC class I-restricted antigenic peptide can be modulated by para-substitution of its buried tyrosine residues in a TCR-specific manner.
Saito NG; Chang HC; Paterson Y
J Immunol; 1999 May; 162(10):5998-6008. PubMed ID: 10229839
[TBL] [Abstract][Full Text] [Related]
24. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
[TBL] [Abstract][Full Text] [Related]
25. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.
Ressing ME; van Leeuwen D; Verreck FA; Gomez R; Heemskerk B; Toebes M; Mullen MM; Jardetzky TS; Longnecker R; Schilham MW; Ottenhoff TH; Neefjes J; Schumacher TN; Hutt-Fletcher LM; Wiertz EJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11583-8. PubMed ID: 14504389
[TBL] [Abstract][Full Text] [Related]
26. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
27. Molecular modelling of co-receptor CD8 alpha alpha and its complex with MHC class I and T-cell receptor in sea bream (Sparus aurata).
Costantini S; Buonocore F; Facchiano AM
Fish Shellfish Immunol; 2008 Dec; 25(6):782-90. PubMed ID: 18951040
[TBL] [Abstract][Full Text] [Related]
28. MHC class I antigen presentation--recently trimmed and well presented.
Flutter B; Gao B
Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
[TBL] [Abstract][Full Text] [Related]
29. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
Godfrey DI; Rossjohn J; McCluskey J
Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
[TBL] [Abstract][Full Text] [Related]
30. Redistribution of critical major histocompatibility complex and T cell receptor-binding functions of residues in an antigenic sequence after biterminal substitution.
Reddehase MJ; Koszinowski UH
Eur J Immunol; 1991 Jul; 21(7):1697-701. PubMed ID: 2060579
[TBL] [Abstract][Full Text] [Related]
31. Pictures of MHC restriction.
Parham P
Nature; 1996 Nov; 384(6605):109-10. PubMed ID: 8906779
[No Abstract] [Full Text] [Related]
32. MHC class I-peptide interactions and TCR recognition.
Young AC; Zhang W; Sacchettini JC; Nathenson SG
Cancer Surv; 1995; 22():17-36. PubMed ID: 7536627
[TBL] [Abstract][Full Text] [Related]
33. What guides MHC-restricted TCR recognition?
Mazza C; Malissen B
Semin Immunol; 2007 Aug; 19(4):225-35. PubMed ID: 17521918
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
Persson K; Schneider G
Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
[TBL] [Abstract][Full Text] [Related]
35. Structural implications for the design of molecular vaccines.
Apostolopoulos V; Yu M; McKenzie IF; Wilson IA
Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650
[TBL] [Abstract][Full Text] [Related]
36. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
[TBL] [Abstract][Full Text] [Related]
37. The shaping of T cell receptor recognition by self-tolerance.
Gras S; Burrows SR; Kjer-Nielsen L; Clements CS; Liu YC; Sullivan LC; Bell MJ; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
Immunity; 2009 Feb; 30(2):193-203. PubMed ID: 19167249
[TBL] [Abstract][Full Text] [Related]
38. T cell antigen receptor recognition of antigen-presenting molecules.
Rossjohn J; Gras S; Miles JJ; Turner SJ; Godfrey DI; McCluskey J
Annu Rev Immunol; 2015; 33():169-200. PubMed ID: 25493333
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.
Strehl B; Seifert U; Krüger E; Heink S; Kuckelkorn U; Kloetzel PM
Immunol Rev; 2005 Oct; 207():19-30. PubMed ID: 16181324
[TBL] [Abstract][Full Text] [Related]
40. Modification of peptide interaction with MHC creates TCR partial agonists.
Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
